VERO - Venus Concept Inc Stock Price, Fair Value and News

$0.320.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

VERO Price Action

Last 7 days

-8.6%

Last 30 days

6.7%

Last 90 days

-61.4%

Trailing 12 Months

-67.7%

VERO RSI Chart

VERO Valuation

Market Cap

2.3M

Price/Earnings (Trailing)

-0.05

Price/Sales (Trailing)

0.03

EV/EBITDA

-0.71

Price/Free Cashflow

-0.29

VERO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VERO Fundamentals

VERO Revenue

Revenue (TTM)

67.2M

Rev. Growth (Yr)

-14.81%

Rev. Growth (Qtr)

-9.5%

VERO Earnings

Earnings (TTM)

-50.3M

Earnings Growth (Yr)

-3.68%

Earnings Growth (Qtr)

53.46%

VERO Profitability

Operating Margin

54.09%

EBT Margin

-74.60%

Return on Equity

-497.82%

Return on Assets

-69.62%

Free Cashflow Yield

-349.01%

VERO Investor Care

Shares Dilution (1Y)

31.22%

Diluted EPS (TTM)

-8.02

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	73.3M	69.8M	67.2M	0
2023	93.6M	86.4M	82.5M	76.4M
2022	109.4M	110.9M	107.8M	99.5M
2021	86.1M	94.9M	98.8M	105.6M
2020	100.3M	89.5M	84.0M	78.0M
2019	41.5M	63.9M	85.2M	110.4M
2018	20.8M	20.5M	21.2M	22.0M
2017	17.9M	20.1M	20.6M	21.3M
2016	16.8M	16.4M	16.0M	15.6M
2015	0	0	0	17.2M

Get all data in R, Python etc through our Historical Stock Data APIs

About Venus Concept Inc

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

CEO	Mr. Rajiv Kanishka Liyanaarchchie De Silva
WEBSITE	venusconcept.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	384

Venus Concept Inc Frequently Asked Questions

What is the ticker symbol for Venus Concept Inc? What does VERO stand for in stocks?

VERO is the stock ticker symbol of Venus Concept Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Venus Concept Inc (VERO)?

As of Fri Dec 20 2024, market cap of Venus Concept Inc is 2.32 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VERO stock?

You can check VERO's fair value in chart for subscribers.

Is Venus Concept Inc a good stock to buy?

The fair value guage provides a quick view whether VERO is over valued or under valued. Whether Venus Concept Inc is cheap or expensive depends on the assumptions which impact Venus Concept Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VERO.

What is Venus Concept Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, VERO's PE ratio (Price to Earnings) is -0.05 and Price to Sales (PS) ratio is 0.03. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VERO PE ratio will change depending on the future growth rate expectations of investors.